Four-Year Complete Remission in a Patient with Metastatic Epidermal Growth Factor Receptor-Mutated Lung Cancer Treated with Two Cycles of Erlotinib.
J Thorac Oncol
; 13(1): e7-e8, 2018 01.
Article
em En
| MEDLINE
| ID: mdl-29258671
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Cloridrato de Erlotinib
/
Neoplasias Pulmonares
/
Antineoplásicos
Tipo de estudo:
Observational_studies
Limite:
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2018
Tipo de documento:
Article